Clinical Trial Update: A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of dimebon (latrepirdine) in Huntington disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Medivation, Inc. | Conditions: Huntington Disease | Phase 3 | Status: COMPLETED